Antibiotic resistance remains a very serious threat due to the limitations of current agents and poor public knowledge about
bacterial infections. The European Antibiotic Awareness Day campaign represents a continuing effort to combat these problems
across the region, but measures are also needed to boost new pharmaceutical industry R&D efforts. Although the 2009 European
Observatory on Health Systems and Policies report was a welcome step forward in summarising thinking of how to stimulate new
industry research, it has not yet prompted governments to implement specific incentives. In 2009, a survey among European
intensive care physicians found that 53% had treated at least one patient infected with a bacterium totally or almost totally
resistant to available antibiotics during the previous 6 months.10 Worrying developments such as these are a warning that governments must bring a sense of urgency to incentivising new antibiotic
1. About European Antibiotic Awareness Day (2008). antibiotic2008.ecdc.europa.eu
2. The overuse of antibiotics — Eurobarometer statistics.
3. E. Mossialos, et al., Policies and incentives for promoting innovation in antibiotic research (2010).
4. Antimicrobial Resistance, Eurobarometer 72.5 (2009). ec.europa.eu
5. Les Antibiotiques, Eurobarometer Special (2003). ec.europa.eu
6. C.A.M. McNulty, J. Antimicrob. Chemo., 65,1526-1533 (2010).
7. S. Coenen, et al., Acta Clinica Belgica, 63-5 (2008).
8. B. Huttner. Antibiotics Are Not Automatic Anymore — The French National Campaign To Cut Antibiotic Overuse. PLoS Medicine
9. L. Jarvis, An Uphill Battle (2008).
10. A. Lepape, Eurosurveillance, 14(45), 12 (2009).